Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
Expression and Clinical Significance of TTF-1 and p63 in NSCLC
Chinese Journal of Lung Cancer, 09/29/09
Zhang P et al. – TTF–1 and p63 might be effective bio–markers for AdC and SCC in NSCLC. They may be a useful marker panel for the identification and differential of lung cancer.
Related Articles
Lung cancer: a biologically different disease in women?
Women's Health, 10/30/09
Relevance Score: 68%
Image-Guided Radiofrequency Ablation of Lung Neoplasm in 100 Consecutive Patients by a Thoracic Surgical Service
Annals of Thoracic Surgery, 10/23/09
Relevance Score: 67%
The Association between Polymorphisms of XPD and Susceptibility of Lung Cancer: A meta Analysis
Chinese Journal of Lung Cancer, 10/21/09
Relevance Score: 67%
hsa-miR-125a-5p Enhances Invasion in Non-small Cell Lung Carcinoma Cell Lines by Upregulating Rock-1
Chinese Journal of Lung Cancer, 10/20/09
Relevance Score: 67%
CYP2E1 Rsa I/Pst I polymorphism is associated with lung cancer risk among Asians
Lung Cancer, 10/06/09
Relevance Score: 67%
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Comparison of the Clinical Effects of Paclitaxel and Paclitaxel plus Oxaliplatin as the Second-line Treatment of Advanced Non-small Cell Lung Cancer
Chinese Journal of Lung Cancer, 12/01/09
The Role of Postoperative Radiotherapy on Stage N2 Non-small Cell Lung Cancer
Chinese Journal of Lung Cancer, 12/01/09
Sleeve lobectomy for patients with non-small-cell lung cancer: a simplified approach
European Journal of Cardio-Thoracic Surgery, 11/30/09
Sponsor
Article Search
Sponsor


See Latest Articles


